|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.804 SEK | +0.45% |
|
+3.09% | +341.08% |
| 07-20 | Medivir Receives Notice of Allowance for Fostrox Plus Lenvatinib Combination Patent in the Usa | CI |
| 07-20 | Medivir Gets Allowance Notice From US Patent Office for Liver Cancer Treatment | MT |
| Market Cap | 1.11B 115M 101M 93.96M 86.43M 162M 10.98B 165M 436M 5.45B 432M 422M 18.82B | P/E 2026 * |
-11.8x | P/E 2027 * | -8.26x |
|---|---|---|---|---|---|
| Enterprise Value | 1.02B 105M 92.22M 85.87M 78.98M 148M 10.04B 151M 399M 4.98B 394M 386M 17.2B | EV / Sales 2026 * |
170x | EV / Sales 2027 * | 6.71x |
| Free-Float |
69.52% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Medivir AB
| 1 day | +0.45% | ||
| 1 week | +3.09% | ||
| Current month | +2.04% | ||
| 1 month | +7.25% | ||
| 3 months | -7.49% | ||
| 6 months | +292.60% | ||
| Current year | +341.08% |
| 1 week | 1.68 |  | 1.88 |
| 1 month | 1.64 | | 1.88 |
| Current year | 0.39 | | 2.88 |
| 1 year | 0.34 | | 2.88 |
| 3 years | 0.34 | | 8.25 |
| 5 years | 0.34 | | 11.84 |
| 10 years | 0.34 | | 102 |
| Manager | Title | Age | Since |
|---|---|---|---|
Jens Lindberg
CEO | Chief Executive Officer | 55 | 2022-01-23 |
Patrik Norgren
DFI | Director of Finance/CFO | - | 2026-03-22 |
Pia Baumann
CTO | Chief Tech/Sci/R&D Officer | 60 | 2023-02-19 |
| Director | Title | Age | Since |
|---|---|---|---|
Uli Alf Hacksell
CHM | Chairman | 76 | 2021-05-04 |
| Director/Board Member | 70 | 2018-05-02 | |
Yilmaz Mahshid
BRD | Director/Board Member | 47 | 2021-05-04 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 6/18/26 | Buy | Chief Financial Officer | 18,000 | 0.0033% | ||
| 6/18/26 | Buy | 144,508 | 0.0268% | |||
| 12/5/25 | Buy | 90,000 | 0.0802% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.45% | +3.09% | -11.78% | -75.01% | 114M | |
| -2.25% | +1.55% | +50.84% | +70.04% | 56.19B | |
| -1.32% | -2.71% | +34.27% | +77.57% | 54.83B | |
| +1.49% | +0.13% | -18.03% | -13.94% | 23.04B | |
| -0.57% | -4.13% | +2.34% | +387.73% | 22.7B | |
| +1.45% | +0.72% | +16.43% | -11.29% | 20.23B | |
| 0.00% | +3.00% | +27.41% | -29.52% | 17.83B | |
| -3.24% | -4.64% | +25.06% | +552.55% | 15.65B | |
| -6.69% | -5.11% | +169.13% | +304.89% | 15.24B | |
| +1.25% | +0.69% | +27.30% | +184.69% | 14.03B | |
| Average | -0.93% | +0.41% | +32.30% | +144.77% | 23.98B | |
| Weighted average by Cap. | -1.17% | -0.21% | +35.63% | +132.55% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 5.98M 617K 541K 504K 464K 869K 58.91M 884K 2.34M 29.22M 2.32M 2.27M 101M | 144M 14.9M 13.07M 12.17M 11.2M 20.99M 1.42B 21.35M 56.53M 706M 55.93M 54.72M 2.44B |
| Net income | -77.84M -8.03M -7.05M -6.56M -6.04M -11.31M -767M -11.51M -30.47M -380M -30.14M -29.49M -1.31B | 33.13M 3.42M 3M 2.79M 2.57M 4.82M 326M 4.9M 12.97M 162M 12.83M 12.55M 559M |
| Net Debt | -96M -9.9M -8.69M -8.09M -7.44M -13.95M -946M -14.19M -37.58M -469M -37.17M -36.37M -1.62B | -145M -14.96M -13.13M -12.22M -11.24M -21.07M -1.43B -21.43M -56.75M -709M -56.15M -54.93M -2.45B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-28 | SEK 1.804 | +0.45% | 1,728,495 |
| 26-07-27 | SEK 1.796 | +4.54% | 1,472,965 |
| 26-07-24 | SEK 1.718 | +1.42% | 701,696 |
| 26-07-23 | SEK 1.694 | -4.29% | 782,712 |
| 26-07-22 | SEK 1.770 | +1.14% | 573,666 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- MVIR B Stock
Select your edition
All financial news and data tailored to specific country editions
